(Q45856784)

17 December 2017

title

Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice (English)

1 reference

17 December 2017

1 reference

5

1 reference

17 December 2017

author name string

Sakurai F

1

1 reference

17 December 2017

Kawabata K

2

1 reference

17 December 2017

Koizumi N

3

1 reference

17 December 2017

Inoue N

4

1 reference

17 December 2017

Yamaguchi T

6

1 reference

17 December 2017

Hayakawa T

7

1 reference

17 December 2017

Mizuguchi H

8

1 reference

17 December 2017

publication date

16 March 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

14

1 reference

17 December 2017

page(s)

1118-1126

1 reference

17 December 2017

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Immune responses to adenovirus and adeno-associated virus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Development and assessment of human adenovirus type 11 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Development of adenovirus serotype 35 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Replication-defective vector based on a chimpanzee adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Mouse adenovirus (MAV-1) expression in primary human endothelial cells and generation of a full-length infectious plasmid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

CD46 is a cellular receptor for group B adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Adenovirus type 11 uses CD46 as a cellular receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Complement-regulatory proteins in ovarian malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Membrane cofactor protein (MCP; CD46) expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Augmented inhibitory effect of superoxide dismutase on superoxide anion release from macrophages by direct cationization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

The structure of the human adenovirus 2 penton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

CD46 in meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Measles virus preferentially transduces the basolateral surface of well-differentiated human airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Intracytoplasmic sperm injection in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Mammalian transgenesis by intracytoplasmic sperm injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Adenovirus vector-mediated doxycycline-inducible RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Optimization of transcriptional regulatory elements for constructing plasmid vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Membrane Cofactor Protein (CD46) Is a Basolateral Protein That Is Not Endocytosed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

7 January 2021

Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

7 January 2021

A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

7 January 2021

Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

7 January 2021

Localization of the complement regulatory proteins in the normal human kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

7 January 2021

Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302749

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302749

1 reference

17 December 2017

Dimensions Publication ID

1019046959

0 references

1 reference

17 December 2017